Rare Cancers – more common than you think
Latest news: Rare Cancers Europe Press Release: Specific clinical trial methodology needed for rare cancers
More than 4 million people in the European Union are affected by rare cancers. Despite the rarity of each of the 186 rare cancers, they represent in total about 22% of all cancer cases, including all cancers in children, diagnosed in the EU27 each year.
Rare Cancers Europe (RCE) is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda and to implementing 39 political and stakeholder recommendations.
10 Oct 2014
Press Release: EMA open to discuss use of complementary methodologies for rare cancers
On 3 October 2014 the European Medicines Agency (EMA) hosted a meeting with representatives of Rare Cancers Europe (RCE) to discuss RCE’s recent...
02 Oct 2014
Press Release: Specific clinical trial methodology needed for rare cancers
A consensus paper published in Annals of Oncology by Rare Cancers Europe (RCE), calls for new methodologies to be applied to clinical studies in rare...
03 Apr 2014
When to Consider Doxorubicin Alone or in Combination With Ifosfamide for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma?